Literature DB >> 25802032

Mycobacterium tuberculosis-specific CD4 T cells are the principal source of IFN-γ in QuantiFERON assays in healthy persons.

Adam Penn-Nicholson1, Elisa Nemes2, Willem A Hanekom2, Mark Hatherill2, Thomas J Scriba2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25802032     DOI： 10.1016/j.tube.2015.03.002

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN： 1472-9792            Impact factor:   3.131


× No keyword cloud information.
  7 in total

1.  Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection.

Authors:  Elisa Nemes; Virginie Rozot; Hennie Geldenhuys; Nicole Bilek; Simbarashe Mabwe; Deborah Abrahams; Lebohang Makhethe; Mzwandile Erasmus; Alana Keyser; Asma Toefy; Yolundi Cloete; Frances Ratangee; Thomas Blauenfeldt; Morten Ruhwald; Gerhard Walzl; Bronwyn Smith; Andre G Loxton; Willem A Hanekom; Jason R Andrews; Maria D Lempicki; Ruth Ellis; Ann M Ginsberg; Mark Hatherill; Thomas J Scriba
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

Review 2.  Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics.

Authors:  Fabrizio Cantini; Carlotta Nannini; Laura Niccoli; Linda Petrone; Giuseppe Ippolito; Delia Goletti
Journal:  Mediators Inflamm       Date:  2017-06-01       Impact factor: 4.711

3.  The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders.

Authors:  Sascha Wilk Michelsen; Bolette Soborg; Lars Jorge Diaz; Soren Tetens Hoff; Else Marie Agger; Anders Koch; Ida Rosenkrands; Jan Wohlfahrt; Mads Melbye
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

4.  Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population.

Authors:  Richard Baguma; Adam Penn-Nicholson; Erica Smit; Mzwandile Erasmus; Jonathan Day; Lebohang Makhethe; Marwou de Kock; E Jane Hughes; Michele van Rooyen; Bernadette Pienaar; Lynnett Stone; Willem Hanekom; Michael J Brennan; Robert S Wallis; Mark Hatherill; Thomas J Scriba
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

5.  Rational engineering of a virulence gene from Mycobacterium tuberculosis facilitates proteomic analysis of a natural protein N-terminus.

Authors:  Cristal Reyna; Felix Mba Medie; Matthew M Champion; Patricia A Champion
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

6.  Activation-Induced Marker Expression Identifies Mycobacterium tuberculosis-Specific CD4 T Cells in a Cytokine-Independent Manner in HIV-Infected Individuals with Latent Tuberculosis.

Authors:  Morgan S Barham; Wendy E Whatney; Jeremiah Khayumbi; Joshua Ongalo; Loren E Sasser; Angela Campbell; Meghan Franczek; Mbuyi Madeleine Kabongo; Samuel G Ouma; Felix Odhiambo Hayara; Neel R Gandhi; Cheryl L Day
Journal:  Immunohorizons       Date:  2020-10-02

7.  Mycobacterium tuberculosis-Specific T Cell Functional, Memory, and Activation Profiles in QuantiFERON-Reverters Are Consistent With Controlled Infection.

Authors:  Cheleka A M Mpande; Pia Steigler; Tessa Lloyd; Virginie Rozot; Boitumelo Mosito; Constance Schreuder; Timothy D Reid; Nicole Bilek; Morten Ruhwald; Jason R Andrews; Mark Hatherill; Francesca Little; Thomas J Scriba; Elisa Nemes
Journal:  Front Immunol       Date:  2021-08-30       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.